Skip to main content
Addgene

pBR322-TIMER
(Plasmid #103056)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 103056 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pBR322
  • Backbone size w/o insert (bp) 4361
  • Vector type
    Bacterial Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    TIMER-bac
  • Alt name
    TIMER
  • Species
    Salmonella enterica, Discosoma spp
  • Mutation
    mutations: S4T and S179T
  • Promoter constitutive ybaJp promoter

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site unknown (unknown if destroyed)
  • 3′ cloning site unknown (unknown if destroyed)
  • 5′ sequencing primer unknown
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

TIMER-bac was generated by exchanging TCC coding for serine 197 to ACC coding for threonine in DsRed.T3_S4T (Sörensen et al., 2003). TIMER-bac was cloned downstream of the constitutively active PybaJ promoter (Rollenhagen and Bumann, 2006) on a pBR322-based plasmid carrying a bla gene conferring resistance to ampicillin (“pBR322_TIMER”).

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pBR322-TIMER was a gift from Dirk Bumann (Addgene plasmid # 103056 ; http://n2t.net/addgene:103056 ; RRID:Addgene_103056)
  • For your References section:

    Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Claudi B, Sprote P, Chirkova A, Personnic N, Zankl J, Schurmann N, Schmidt A, Bumann D. Cell. 2014 Aug 14;158(4):722-733. doi: 10.1016/j.cell.2014.06.045. 10.1016/j.cell.2014.06.045 PubMed 25126781